Apyx Medical reports Q4 net loss of $1.3M, revenue hits $19.2M
Apyx Medical (NASDAQ:APYX), an advanced energy technology company proprietary to the Renuvion® helium plasma platform, reported a net loss of $1.3 million for its fourth quarter on Tuesday.










